Analysis of gene mutations involved in chloroquine resistance in Plasmodium falciparum parasites isolated from patients in the southwest of Saudi Arabia

Annals of Saudi Medicine

Volumn 30, Issue 3, 2010, Pages 187-192

  Bin Dajem, Saad M ^a   Al Qahtani, Ahmed ^b  

^a KING KHALID UNIVERSITY   (Saudi Arabia)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE;

AMPLICON; ARTICLE; DNA EXTRACTION; DNA SEQUENCE; GENE; GENE AMPLIFICATION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; PARASITE ISOLATION; PFCRT GENE; PFMDR1 GENE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SAUDI ARABIA;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; DRUG RESISTANCE, MULTIPLE; GENE AMPLIFICATION; GENETIC VARIATION; HUMANS; MALARIA, FALCIPARUM; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MUTATION; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; SAUDI ARABIA;

EID: 77952302755     PISSN: 02564947     EISSN: 09754466     Source Type: Journal    
DOI: 10.4103/0256-4947.62826     Document Type: Article

References (45)

1. Greenwood B, Mutabingwa T. Malaria in 2002. Nature 2002;415:670-672
2. WHO. 2008. Available from: http://www.apps. who.int/malaria/wmr2008/ malaria2008.pdf
3. Nahlen BL, Korenromp EL, Miller JM, Shibuya K. Malaria risk: estimating clinical episodes of malaria. Nature 2005;437:E3.
4. WHO/ EMRO, 2006. Available from: http://www. emro.who.int/index.asp.
5. Malik GM, Seidi O, El-Taher A, Mohammed AS. Clinical Aspects of Malaria in the Asir Region, Saudi Arabia. Ann Saudi Med 1998;18:15-17
6. Bashwari LA, Mandil AM, Bahnassy AA, Al- Shamsi MA, Bukhari HA. Epidemiological profile of malaria in a university Hospital in the Eastern Region of Saudi Arabia. Saudi Med J 2001;22:133-138
7. Al-Tawfiq JA. Epidemiology of travel-related malaria in a non-malarious area in Saudi Arabia. Saudi Med J 2006;27:86-89
8. Ministry of Health. 2006 (annual statistics book), MOH. Saudi Arabia.
9. Alkhalife IS. Imported Malaria infections diagnosed at the malaria referral laboratory in Riyadh, Saudi Arabia. Saudi Med J 2003;24:1068-1072
10. Ghalib HW, Al-Ghamdi S, Akood M, Haridi AE, Ageel AA, Abdalla RE. Therapeutic efficacy of chloroquine against uncomplicated, plasmodium falciparum malaria in south-western Saudi Arabia. Ann Trop Med Parasitol 2001;95:773-779
11. Fitch CD, Russell NV. Accelerated denaturation of hemoglobin and the antimalarial action of chloroquine. Antimicrob Agents Chemother 2006;50:2415-2419
12. Bray PG, Mungthin M, Hastings IM, Biagini GA, Saidu DK, Lakshmanan V, et al. PfCRT and the trans-vacuolar proton electrochemical gradient: regulating the access of chloroquine to ferriprotoporphyrin IX. Mol Microbiol 2006;62:238-251
13. Ashley EA, White NJ. Artemisinin-based combinations. Curr Opin Infect Dis 2005;18:531-536
14. Abdel-Hameed AA. Antimalarial drug resistant in the Eastern Mediterranean Region. East Mediterr Health J 2003;9:492-508.
15. Alrajhi AA, Rahim I, Akood M, Hazmi M. Chloroquine- Resistant Plasmodium falciparum cerebral Malaria in achloroquine-Susceptible Area. J Infect Dis 1999;180:1738-1741
16. Al Harthi SA. Detection of drug resistance markers for chloroquine and pyrimethamine-sulfadoxinein Jazan area, Saudi Arabia using PCR and restriction digestion. J Egypt Soc Parasitol 2007;37:17-30.
17. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, et al. Mutations in the P.falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 2000;6:861-871
18. Chen N, Kyle DE, Pasay C, Fowler EV, Baker J, Peters JM, et al. pfcrt allelic types with two novel amino acid mutations in chloroquine-resistant Plasmodium falciparum isolates from the Philippines. Antimicrob Agents Chemother 2003;47:3500-3505
19. Hayton K, Su XZ. Genetic and biochemical aspects of drug resistance in malaria parasites. Curr Drug Targets Infect Disord 2004;4:1-10.
20. Foote SJ, Galatis D, Cowman AF. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proc Natl Acad Sci USA 1990;87:3014-3017
21. Basco LK, Le Bras J, Rhoades Z, Wilson CM. Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from subsaharan Africa. Mol Biochem Parasitol 1995;74:157-166
22. Nagesha HS, Din-Syafruddin, Casey GJ, Susanti AI, Fryauff DJ, Reeder JC, et al. Mutations in the pfmdr, dhfr, dhps genes of Plasmodium falciparum are associated with in vivo-drug resistance in West Papua, Indonesia. Trans R Soc Trop Med Hyg 2001;95:43-49
23. Sakihama N, Mitamura T, Kaneko A, Horii T, Tanabe K. Long PCR amplification of Plasmodium falciparum DNA extracted from filter paper blots. Exp Parasitol 2001;97:50-54
24. Djimde A, Doumbo OK, Corteses JF. A molecular markers for chloroquine-resistant falciparum malaria. N Engl J Med 2001;344:257-263
25. Foley M, Tilley L. Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents. Pharmacol Ther 1998;79:55-87.
26. Sutherland CJ, Alloueche A, Curtis J, Drakeley CJ, Ord R, Duraisingh M, et al. Gambian children successfully treated with chloroquine can harbor and transmit Plasmodium falciparum gametocytes carrying resistance genes. Am J Trop Med Hyg 2002;67:578-585
27. Vinayak S, Biswas S, Dev V, Kumar A, Ansari MA, Sharma YD. Prevalence of the K76T mutation in the pfcrt gene of Plasmodium falciparum among chloroquine responders in India. Acta Trop 2003;87:287-293
28. Duraisingh MT, Cowman AF. Contribution of the pfmdr1 gene to antimalarial drug-resistance. Acta Trop 2005;94:181-190
29. Anderson TJ, Nair S, Qin H, Singlam S, Brockman A, Paiphun L, et al. Are transporter genes other than the chloroquine resistance locus (pfcrt) and multidrug resistance gene (pfmdr) associated with antimalarial drug resistance? Antimicrob Agents Chemother 2005;49:2180-2188
30. Sanchez CP, Stein WD, Lanzer M. Is PfCRT a channel or a carrier? Two competing models explaining chloroquine resistance in Plasmodium falciparum. Trends Parasitol 2007;23:332-339
31. Dorsey G, Kamya MR, Singh A, Rosenthal PJ. Polymorphisms in the plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda. J Infect Dis 2001;183:1417-1420
32. Ursing J, Zakeri S, Gil JP, Bjorkman A. Quinoline resistance associated polymorphisms in the pfcrt, pfmdr1 and pfmrp genes of Plasmodiumm falciparum in Iran. Acta Trop 2006;97:352-356
33. Rungsihirunrat K, Chaijareonkul W, Seugorn A, Na-Bangchang K, Thaithong S. Association between chloroquine resistance phenotypes and point mutations in pfcrt and pfmdr1 in Plasmodium falciparum isolates from Thailand. Acta Trop 2009;109:37-40.
34. Yang Z, Zhang Z, Sun X, Wan W, Cui L, Zhang X, et al. Molecular analysis of chloroquine resistance in Plasmodium falciparum in Yunnan Province, China. Trop Med Int Health 2007;12:1051-1060
35. Severini C, Menegon M, Sannella AR, Paglia MG, Narciso P, Matteelli A, et al. Prevalence of pfcrt point mutations and level of chloroquine resistance in Plasmodium falciparum isolates from Africa. Infect Genet Evol 2006;6:262-268
36. Mita T, Kaneko A, Hombhanje F, Hwaihwanje I, Takahashi N, Osawa H, et al. Role of pfmdr1 mutations on chloroquine resistance in Plasmodium falciparum isolates with pfcrt K76T from Papua New Guinea. Acta Trop 2006;98:137-144
37. Hatabu T, Iwagami M, Kawazu S, Taguchi N, Escueta AD, Villacorte EA, et al. Association of molecular markers in Plasmodium falciparum crt and mdr1 with in vitro chloroquine resistance: A Philippine study. Parasitol Int 2009;58:166-170
38. Cooper RA, Hartwig CL, Ferdig MT. Pfcrt is more than the Plasmodium falciparum chloroquine resistance gene: a functional and evolutionary perspective. Acta Trop 2005;94:170-180
39. Vathsala PG, Pramanik A, Dhanasekaran S, Devi CU, Pillai CR, Subbarao SK, et al. Widespread occurrence of the Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene haplotype svmnt in P. falciparum malaria in India. Am J Trop Med Hyg 2004;70:256-259
40. Pati SS, Mishra S, Mohanty S, Mohapatra DN, Sahu PK, Priyadarshi N, et al. Pfcrt haplotypes and in-vivo chloroquine response in Sundergarh district, Orissa, India. Trans R Soc Trop Med Hyg 2007;101:650-654
41. Duraisingh MT, Drakeley CJ, Muller O, Bailey R, Snounou G, Targett GA, et al. Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine. Parasitology 1997;114:205-211
42. Jalousian F, Dalimi A, Samiee SM, Ghaffarifar F, Soleymanloo F, Naghizadeh R. Mutation in pfmdr1 gene in chloroquine-resistant Plasmodium falciparum isolates, Southeast Iran. Int J Infect Dis 2008;12:630-634
43. Mawili-Mboumba DP, Kun JF, Lell B, Kremsner PG, Ntoumi F. Pfmdr1 alleles and response to ultra low dose mefloquine treatment in Gabonese patients. Antimicrob Agents Chemother 2002;46:166-170
44. Babiker HA, Pringle SJ, Abdel-Muhsin A, Mackinnon M, Hunt P, Walliker D. High level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene (pfcrt) and multidrug resistance gene (pfmdr1). J Infect Dis 2001;183:1535-1538
45. Abdel-Muhsin AM, Mackinnon MJ, Ali E, Nassir el-KA, Suleiman S, Ahmed S, et al. Evolution of Drug-Resistance Genes in Plasmodium falciparum in an Area of Seasonal Malaria Transmission in Eastern Sudan. J Infect Dis 2004;189:1239-1244